Marshall Wace’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,800
Closed -$288K 2740
2025
Q1
$288K Buy
+16,800
New +$313K ﹤0.01% 2285
2024
Q3
Sell
-40,854
Closed -$767K 2542
2024
Q2
$767K Buy
+40,854
New +$730K ﹤0.01% 1795
2023
Q3
Sell
-24,169
Closed -$366K 2234
2023
Q2
$366K Buy
24,169
+3,756
+18% +$52.6K ﹤0.01% 2083
2023
Q1
$278K Buy
20,413
+7,777
+62% +$113K ﹤0.01% 2321
2022
Q4
$161K Buy
+12,636
New +$171K ﹤0.01% 2727
2022
Q1
Sell
-16,982
Closed -$299K 3401
2021
Q4
$299K Buy
+16,982
New +$326K ﹤0.01% 3035

Other funds holding CCAP

Marshall Wace's CCAP Position: Q2 2025 in Review

Marshall Wace sold out of Crescent Capital BDC (CCAP) in Q2 2025, closing a stake of 16,800 shares — an estimated $288K sold.

Marshall Wace first reported a position in CCAP in Q4 2021 and held it in 6 quarters. The position peaked at $767K in Q2 2024. 89 funds tracked by Wall St. Rank hold CCAP as of Q2 2025.

  • Marshall Wace reported no remaining Crescent Capital BDC position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 16,800 Crescent Capital BDC shares in Q2 2025, an estimated $288K.
  • Marshall Wace first reported a position in Crescent Capital BDC in Q4 2021 and held it in 6 quarters.
  • Marshall Wace's Crescent Capital BDC position peaked at $767K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.